B
United Therapeutics Corporation UTHR
$307.24 $1.850.61%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024
Revenue -1.74% 4.76%
Total Other Revenue -- --
Total Revenue -1.74% 4.76%
Cost of Revenue -8.66% 6.81%
Gross Profit -0.87% 4.50%
SG&A Expenses 6.62% -13.23%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 9.77% -13.75%
Operating Income -11.34% 27.60%
Income Before Tax 2.03% 9.37%
Income Tax Expenses 19.75% 2.98%
Earnings from Continuing Operations -2.52% 11.15%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -2.52% 11.15%
EBIT -11.34% 27.60%
EBITDA -10.70% 26.20%
EPS Basic -2.74% 10.65%
Normalized Basic EPS -10.85% 26.11%
EPS Diluted -3.22% 9.23%
Normalized Diluted EPS -11.20% 24.32%
Average Basic Shares Outstanding 0.22% 0.45%
Average Diluted Shares Outstanding 0.62% 1.89%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings